FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Hill Christopher Scott

2. Date of Event Requiring Statement (MM/DD/YYYY)
4/30/2015 

3. Issuer Name and Ticker or Trading Symbol

CORE LABORATORIES N V [CLB]

(Last)        (First)        (Middle)

6316 WINDFERN ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Chief Accounting Officer /

(Street)

HOUSTON, TX 77040       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Shares   8183   D    
Common Shares   59   I   401(k) Plan  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Shares     (1)   (1) Common Shares   2140.0   (1) $0.0   D    
Performance Shares     (2)   (2) Common Shares   3000.0   (2) $0.0   D    

Explanation of Responses:
( 1)  Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the respective grant date. Mr. Hill has six grants still outstanding, and of those the following shares remain unvested at this time: 300 shares from the grant on 06/30/2009, 300 shares from the grant on 10/01/2010, 375 shares from the grant on 12/01/2011, 500 shares from the grant on 09/01/2012, 400 shares from the grant on 03/01/2013, and 265 shares from the grant on 04/01/2014.
( 2)  Assuming his continued employment (or death or disability while employed) and the satisfaction of certain performance goals is achieved, this award would vest at the end of a three-year performance period that began on January 1, 2015 and ends on the last NYSE trading day of December 2017 (the "Performance Period"). The restricted performance shares will vest only upon the Company's return on invested capital being in the top decile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period. If this criteria is not met, then no shares shall vest and the award shall be forfeited.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Hill Christopher Scott
6316 WINDFERN ROAD
HOUSTON, TX 77040


Chief Accounting Officer

Signatures
/s/ Mark Elvig, Attorney-in-Fact 5/7/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Core Laboratories (NYSE:CLB)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Core Laboratories Charts.
Core Laboratories (NYSE:CLB)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Core Laboratories Charts.